Bora Lim, MD

UT MD Anderson Cancer Center · UT MD Anderson · M.D. Anderson Cancer Center

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers in breast cancer

PubMed author-name match

Trials

Studies that name Bora Lim, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:20 UTC. Open this list on ClinicalTrials.gov

Ph1
NCT07783659 · Zotatifin And EIF4A Platinum Helix Inhibition In Resistant AdvancedTNBC
M.D. Anderson Cancer Center · not yet recruiting · Phase IB, Zotatifin, EIF4A · principal investigator
Ph1
NCT07553390 · Phase 1b Study Of TRICK-NK In Combination With T-Dxd In Treatment-Refractory Breast Cancers
M.D. Anderson Cancer Center · not yet recruiting · Breast Cancer · principal investigator
Ph1
NCT06959537 · A Phase Ib Study of Novel Combination (New) of Low Dose Oral CyclophoSphamide (s) to Potentiate Axatilimab (A) + Retifanlimab (R) in Treating Metastatic Triple Negative Breast Cancer (TNBC)
M.D. Anderson Cancer Center · suspended · Breast Cancer · principal investigator
Ph2
NCT02971748 · Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy
M.D. Anderson Cancer Center · active not recruiting · Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Breast Inflammatory Carcinoma · principal investigator
Ph2
NCT02411656 · Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy
M.D. Anderson Cancer Center · active not recruiting · Edema, Erythema, Estrogen Receptor Negative · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

PubMed returned no clinical-trial papers for this author name in breast cancer.